XML 42 R34.htm IDEA: XBRL DOCUMENT v3.22.1
Borrowings (Details)
€ in Thousands, $ in Millions
1 Months Ended 3 Months Ended
Dec. 29, 2021
shares
Jul. 14, 2020
shares
Aug. 31, 2020
EUR (€)
tranche
Jul. 31, 2020
USD ($)
tranche
Mar. 31, 2022
EUR (€)
Mar. 31, 2022
USD ($)
Dec. 31, 2021
EUR (€)
Dec. 10, 2018
EUR (€)
Disclosure of detailed information about borrowings [line items]                
Total borrowings         € 44,762   € 44,090  
Current portion         (6,394)   (4,771)  
Non Current portion         38,368   39,319  
Innovation credit                
Disclosure of detailed information about borrowings [line items]                
Accrued interest         742   645  
Total borrowings         3,907   3,907  
Interest rate (as percent)               10.00%
Innovation credit | Maximum                
Disclosure of detailed information about borrowings [line items]                
Notional amount               € 4,700
Convertible loans                
Disclosure of detailed information about borrowings [line items]                
Accrued interest         653   613  
Total borrowings         € 39,460   € 38,925  
Convertible loans | Minimum                
Disclosure of detailed information about borrowings [line items]                
Unconvertible Debt Maturity         24 months      
Convertible Debt                
Disclosure of detailed information about borrowings [line items]                
Number of Shares Exercisable for Issued Warrants | shares   302,676            
Number of shares exercisable for issued warrants | shares   302,676            
Convertible loans Amylon Therapeutics B.V. [Member]                
Disclosure of detailed information about borrowings [line items]                
Interest rate (as percent)         8.00% 8.00%    
Debt instrument convertible term         36 months      
Convertible loans Amylon Therapeutics B.V. [Member] | Maximum                
Disclosure of detailed information about borrowings [line items]                
Unconvertible Debt Maturity         36 months      
Convertible Debt Pontifax Medison and Kreos Capital Debt Financing | Maximum                
Disclosure of detailed information about borrowings [line items]                
Number of Shares Exercisable for Issued Warrants | shares 376,952              
Number of shares exercisable for issued warrants | shares 376,952              
Convertible Debt Pontifax Medison Debt Financing                
Disclosure of detailed information about borrowings [line items]                
Total borrowings         € 8,800 $ 10    
Number of tranches | tranche       3        
Maximum borrowing capacity per tranche | $       $ 10        
Term of debt       54 months        
Debt, interest only payment term       24 months        
Convertible Debt Pontifax Medison Debt Financing | Maximum                
Disclosure of detailed information about borrowings [line items]                
Notional amount | $       $ 30        
Convertible Debt Kreos Capital Debt Financing                
Disclosure of detailed information about borrowings [line items]                
Total borrowings         € 5,000      
Number of tranches | tranche     3          
Maximum borrowing capacity per tranche     € 5,000          
Term of debt     54 months          
Debt, interest only payment term     24 months          
Convertible Debt Kreos Capital Debt Financing | Maximum                
Disclosure of detailed information about borrowings [line items]                
Notional amount     € 15,000          
Convertible Debt Pontifax Medison and Kreos Capital Debt Financing, amended agreement                
Disclosure of detailed information about borrowings [line items]                
Total borrowings | $           $ 30    
Term of debt 54 months              
Debt, interest only payment term 33 months